Breaking News, Financial News

Financial Report: Thermo Fisher Scientific

Revenues up 6% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Thermo Fisher Scientific

4Q Revenues: $3.3 billion (+6%)

4Q Earnings: $376.4 million (+12%)

FY Revenues: $12.5 billion (+8%)

FY Earnings: $1.2 billion (+9%)

Comments: Analytical Technologies Segment revenue was up 2% to $1.1 billion in the quarter. Specialty Diagnostics Segment revenue increased 12% to $792 million. Laboratory Products and Services Segment revenue increased 4% to $1.5 billion.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters